Annual Cash & Cash Equivalents
$376.00 K
-$4.76 M-92.69%
April 30, 2024
Summary
- As of February 25, 2025, ALZN annual cash & cash equivalents is $376.00 thousand, with the most recent change of -$4.76 million (-92.69%) on April 30, 2024.
- During the last 3 years, ALZN annual cash & cash equivalents has fallen by -$1.55 million (-80.51%).
- ALZN annual cash & cash equivalents is now -97.33% below its all-time high of $14.06 million, reached on April 30, 2022.
Performance
ALZN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.09 M
+$2.90 M+242.81%
October 31, 2024
Summary
- As of February 25, 2025, ALZN quarterly cash and cash equivalents is $4.09 million, with the most recent change of +$2.90 million (+242.81%) on October 31, 2024.
- Over the past year, ALZN quarterly cash and cash equivalents has increased by +$2.90 million (+242.81%).
- ALZN quarterly cash and cash equivalents is now -73.79% below its all-time high of $15.62 million, reached on July 31, 2021.
Performance
ALZN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ALZN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -92.7% | +242.8% |
| 3 y3 years | -80.5% | +242.8% |
| 5 y5 years | +782.6% | +242.8% |
ALZN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -97.3% | at low | -70.9% | +1945.5% |
| 5 y | 5-year | -97.3% | +782.6% | -73.8% | +9956.8% |
| alltime | all time | -97.3% | +782.6% | -73.8% | +9956.8% |
Alzamend Neuro Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $4.09 M(+242.8%) |
| Jul 2024 | - | $1.19 M(+217.6%) |
| Apr 2024 | $376.00 K(-92.7%) | $376.00 K(+32.9%) |
| Jan 2024 | - | $282.90 K(+41.4%) |
| Oct 2023 | - | $200.10 K(-88.2%) |
| Jul 2023 | - | $1.70 M(-67.0%) |
| Apr 2023 | $5.14 M | $5.14 M(-30.3%) |
| Jan 2023 | - | $7.38 M(-19.7%) |
| Oct 2022 | - | $9.18 M(-20.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2022 | - | $11.53 M(-18.0%) |
| Apr 2022 | $14.06 M(+629.0%) | $14.06 M(+19.3%) |
| Jan 2022 | - | $11.79 M(-13.1%) |
| Oct 2021 | - | $13.57 M(-13.1%) |
| Jul 2021 | - | $15.62 M(+709.5%) |
| Apr 2021 | $1.93 M(+2036.5%) | $1.93 M(+4640.3%) |
| Jan 2021 | - | $40.70 K(-54.9%) |
| Apr 2020 | $90.30 K(+112.0%) | $90.30 K |
| Apr 2019 | $42.60 K | - |
FAQ
- What is Alzamend Neuro annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Alzamend Neuro?
- What is Alzamend Neuro annual cash & cash equivalents year-on-year change?
- What is Alzamend Neuro quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Alzamend Neuro?
- What is Alzamend Neuro quarterly cash and cash equivalents year-on-year change?
What is Alzamend Neuro annual cash & cash equivalents?
The current annual cash & cash equivalents of ALZN is $376.00 K
What is the all time high annual cash & cash equivalents for Alzamend Neuro?
Alzamend Neuro all-time high annual cash & cash equivalents is $14.06 M
What is Alzamend Neuro annual cash & cash equivalents year-on-year change?
Over the past year, ALZN annual cash & cash equivalents has changed by -$4.76 M (-92.69%)
What is Alzamend Neuro quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ALZN is $4.09 M
What is the all time high quarterly cash and cash equivalents for Alzamend Neuro?
Alzamend Neuro all-time high quarterly cash and cash equivalents is $15.62 M
What is Alzamend Neuro quarterly cash and cash equivalents year-on-year change?
Over the past year, ALZN quarterly cash and cash equivalents has changed by +$2.90 M (+242.81%)